Compound Detail
CHEMBL4582357
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCC(CC)n1cnc2c(NCc3c(C)cc(C)[nH]c3=O)nc(-c3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)nc3)nc21
Basic Information
| ChEMBL ID | CHEMBL4582357 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZBBBZRTYBPOKAL-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
601.8
MW (Da)
5.22
ALogP
10
HBA
2
HBD
134.2
PSA (Ų)
0.28
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.28
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 520.0 | nM | 6.28 | Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay | 31610375 |
| HCT-116 | IC50 | = | 880.0 | nM | 6.06 | Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay | 31610375 |
| A549 | IC50 | = | 8210.0 | nM | 5.09 | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | 31610375 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31610375 | 10.1016/j.ejmech.2019.111728 | HepG2 | 1 |
| 31610375 | 10.1016/j.ejmech.2019.111728 | A549 | 1 |
| 31610375 | 10.1016/j.ejmech.2019.111728 | HCT-116 | 1 |
Data from ChEMBL 36 via Core Engine